Kardio-torakochirurgia i chirurgia naczyniowa
Leczenie niedokrwistości przedoperacyjnej i optymalizacja obrazu krwi
Ferric carboxymaltose in patients with heart failure and iron deficiency. (opens new window)
Źródło: N Engl J Med 2009;361(25):2436-48.
Indeks: PubMed 19920054
DOI: 10.1056/NEJMoa0908355
https://www.ncbi.nlm.nih.gov/pubmed/19920054 (opens new window)
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (opens new window)
Źródło: Vasc Endovascular Surg 2007;41(5):460-2.
Indeks: PubMed 17942864
DOI: 10.1177/1538574407303172
https://www.ncbi.nlm.nih.gov/pubmed/17942864 (opens new window)
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (opens new window)
Źródło: Catheter Cardiovasc Interv 2014;83(6):E221-6.
Indeks: PubMed 24402965
DOI: 10.1002/ccd.25389
https://www.ncbi.nlm.nih.gov/pubmed/24402965 (opens new window)
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (opens new window)
Źródło: Anesth Analg 2019;128(5):981-92.
Indeks: PubMed 30649068
DOI: 10.1213/ANE.0000000000004005
https://www.ncbi.nlm.nih.gov/pubmed/30649068 (opens new window)
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (opens new window)
Źródło: Can J Cardiol 2014;30(Suppl):S234.
DOI: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (opens new window)
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (opens new window)
Źródło: Am J Cardiol 2012;110(7):1021-6.
Indeks: PubMed 22771376
DOI: 10.1016/j.amjcard.2012.05.036
https://www.ncbi.nlm.nih.gov/pubmed/22771376 (opens new window)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (opens new window)
Źródło: Eur J Heart Fail 2013;15(11):1267-76.
Indeks: PubMed 23787722
DOI: 10.1093/eurjhf/hft099
https://www.ncbi.nlm.nih.gov/pubmed/23787722 (opens new window)
Current status of pharmacologic therapies in patient blood management. (opens new window)
Źródło: Anesth Analg 2013;116(1):15-34.
Indeks: PubMed 23223098
DOI: 10.1213/ANE.0b013e318273f4ae
https://www.ncbi.nlm.nih.gov/pubmed/23223098 (opens new window)
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (opens new window)
Źródło: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
Indeks: PubMed 26809765
DOI: 10.1053/j.jvca.2015.10.021
https://www.ncbi.nlm.nih.gov/pubmed/26809765 (opens new window)
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (opens new window)
Źródło: Transfusion 2008;48(4):666-72.
Indeks: PubMed 18194382
DOI: 10.1111/j.1537-2995.2007.01590.x
https://www.ncbi.nlm.nih.gov/pubmed/18194382 (opens new window)
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (opens new window)
Źródło: Br J Anaesth. 2022;128(5):796-805.
Indeks: PubMed 35256150
DOI: 10.1016/j.bja.2022.01.034
https://pubmed.ncbi.nlm.nih.gov/35256150/ (opens new window)
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (opens new window)
Źródło: Transfus Med Rev 2013;27(4):221-34.
Indeks: PubMed 24135037
DOI: 10.1016/j.tmrv.2013.09.001
https://www.ncbi.nlm.nih.gov/pubmed/24135037 (opens new window)
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (opens new window)
Źródło: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
Indeks: PubMed 23998782
DOI: 10.1016/j.jtcvs.2013.06.033
https://www.ncbi.nlm.nih.gov/pubmed/23998782 (opens new window)
Jehovah's Witnesses and cardiac surgery: a single institution's experience. (opens new window)
Źródło: Transfusion 2014;54(10 Pt 2):2745-52.
Indeks: PubMed 24809815
DOI: 10.1111/trf.12696
https://www.ncbi.nlm.nih.gov/pubmed/24809815 (opens new window)
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (opens new window)
Źródło: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
Indeks: PubMed 33483268
DOI: 10.1053/j.jvca.2020.12.044
https://pubmed.ncbi.nlm.nih.gov/33483268/ (opens new window)
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (opens new window)
Źródło: Surg Infect (Larchmt) 2009;10(1):9-19.
Indeks: PubMed 19245362
DOI: 10.1089/sur.2008.043
https://www.ncbi.nlm.nih.gov/pubmed/19245362 (opens new window)
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (opens new window)
Źródło: Anaesthesia 2020;75(8):1039-49.
Indeks: PubMed 32342498
DOI: 10.1111/anae.15062
https://www.ncbi.nlm.nih.gov/pubmed/32342498 (opens new window)
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (opens new window)
Źródło: J Vasc Surg 2003;37(2):453-5.
Indeks: PubMed 12563221
DOI: 10.1067/mva.2003.73
https://www.ncbi.nlm.nih.gov/pubmed/12563221 (opens new window)
Intravenous iron in heart failure: beyond targeting anemia. (opens new window)
Źródło: Curr Heart Fail Rep 2011;8(1):14-21.
Indeks: PubMed 21057903
DOI: 10.1007/s11897-010-0034-4
https://www.ncbi.nlm.nih.gov/pubmed/21057903 (opens new window)
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (opens new window)
Źródło: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
Indeks: PubMed 26211405
DOI: 10.1016/j.jtcvs.2015.06.059
https://www.ncbi.nlm.nih.gov/pubmed/26211405 (opens new window)
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (opens new window)
Źródło: J Nephrol 2008;21(2):236-42.
Indeks: PubMed 18446719
https://www.ncbi.nlm.nih.gov/pubmed/18446719 (opens new window)
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (opens new window)
Źródło: J Thorac Cardiovasc Surg 2010;139(3):621-7.
Indeks: PubMed 20042202
DOI: 10.1016/j.jtcvs.2009.10.012
https://www.ncbi.nlm.nih.gov/pubmed/20042202 (opens new window)
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (opens new window)
Źródło: Transfusion 2015;55(7):1644-54.
Indeks: PubMed 25702777
DOI: 10.1111/trf.13027
https://www.ncbi.nlm.nih.gov/pubmed/25702777 (opens new window)
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (opens new window)
Źródło: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
Indeks: PubMed 25847415
DOI: 10.1053/j.jvca.2014.10.022
https://www.ncbi.nlm.nih.gov/pubmed/25847415 (opens new window)
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (opens new window)
Źródło: Anesthesiology 2011;115(5):929-37.
Indeks: PubMed 22027622
DOI: 10.1097/ALN.0b013e318232004b
https://www.ncbi.nlm.nih.gov/pubmed/22027622 (opens new window)